Focal Adhesion Kinase Activation Mediates IQ Motif-Containing GTPase-Activating Protein 3-Promoted Lung Metastasis in...

Area of Science:

• Oncology
• Molecular Biology
• Cancer Metastasis

Background:

• Osteosarcoma (OS) is a primary bone cancer with high metastatic potential and poor patient outcomes.
• Identifying molecular drivers of OS progression is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of IQGAP3 in osteosarcoma (OS) progression and metastasis.
• To elucidate the molecular mechanisms underlying IQGAP3-mediated OS metastasis.
• To identify potential therapeutic targets for OS.

Main Methods:

• Bioinformatics and clinical tissue analysis to assess IQGAP3 expression.
• In vitro and in vivo functional assays to evaluate IQGAP3's role in cell migration, invasion, and metastasis.
• Transcriptomic analysis to identify signaling pathways associated with IQGAP3.
• Molecular assays to determine protein interactions and phosphorylation status.
• Pharmacological inhibition and activation of key signaling molecules.
• Reporter assays to identify upstream regulators of IQGAP3.

Main Results:

• IQGAP3 expression is significantly elevated in osteosarcoma and correlates with poor prognosis.
• IQGAP3 promotes OS cell migration, invasion, and lung metastasis.
• IQGAP3 interacts with Focal Adhesion Kinase (FAK), enhancing its phosphorylation and activating downstream signaling.
• IQGAP3 influences the GSK-3β/β-catenin axis via FAK and Wnt pathway signaling.
• ZEB1 acts as a direct upstream regulator, promoting IQGAP3 expression.

Conclusions:

• A novel ZEB1/IQGAP3/FAK/β-catenin signaling axis critically drives osteosarcoma lung metastasis.
• IQGAP3 is a key molecular driver of OS progression and metastasis.
• This signaling axis represents a potential therapeutic target for osteosarcoma intervention.